NCT00046137已完成3 期
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 13
研究概览
简要总结
The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 45 Years 至 85 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Must be diagnosed with osteoporosis.
- •Must be female, age 45 through
- •Must be at least 5 years postmenopausal.
- •Must be free of other severe or chronically disabling conditions.
- •Must be able to properly use injection device.
排除标准
- •Must not have bone diseases other than osteoporosis.
- •Must not have history of certain cancers.
- •Must not have certain medical diseases (inflammatory bowel disease, malabsorption syndrome, kidney or bladder stones, venous thrombi or emboli, recent vaginal bleeding due to unknown causes).
- •Must not have taken or are currently taking certain types of medicines.
- •Must not have known allergy to the study agent or SERM.
研究者
研究点 (13)
Loading locations...
相似试验
已完成
4 期
VERtebral Fracture Treatment Comparisons in Osteoporotic WomenPostmenopausal OsteoporosisNCT01709110Eli Lilly and Company1,366
已完成
3 期
Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced OsteoporosisOsteoporosisNCT00503399Eli Lilly and Company92
已完成
1 期
A Comparison Study of PF708 and Forteo in Healthy SubjectsOsteoporosisNCT02656810Pfenex, Inc70
Unknown
1 期
Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior ChemotherapySmall Cell Lung CancerNCT02446704Zofia Piotrowska66
Unknown
不适用
Effects of Terlipressin When Usual Somatostatin or Octreotide Dose FailsEsophageal and Gastric VaricesHemorrhageLiver CirrhosisNCT02311608Shanghai Zhongshan Hospital1,320